ANASTASIA KOVALASKE: Open Payments
NPI 1790118586 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 72 payments from 21 companies in 2025. Trend: 2023 $1,480 · 2024 $1,125 · 2025 $1,407
Food & beverage: $1,322Education: $85
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $252 |
| Janssen Biotech, Inc. | 9 | $241 |
| Olympus America Inc. | 7 | $139 |
| Endo USA, Inc. | 6 | $124 |
| ABBVIE INC. | 5 | $103 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $78 |
| TOLMAR, INC. | 4 | $59 |
| Medtronic, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $43 |
Products named: GEMTESA, ERLEADA, iTIND System, XIAFLEX, KEYTRUDA, LUPRON DEPOT, PYLARIFY, RYBREVANT.
Industry payments across IL — which companies pay providers there.
